NMTC - NeuroOne Medical Technologies Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-09-30
2021-09-30
2020-09-30
2019-09-30
Total Revenue
252
171.169
178.146
1,927
0
Cost of Revenue
322.005
241.963
275.895
-
-
Gross Profit
-70.005
-70.794
-97.749
-
-
Operating Expenses
Research Development
5,432
4,929
3,925
2,076
1,529
Selling General and Administrative
6,901
6,979
6,260
4,753
4,284
Total Operating Expenses
8,936
9,960
10,120
6,829
5,813
Operating Income or Loss
-9,006
-10,031
-10,218
-4,902
-5,813
Interest Expense
-
0
3.053
7,525
284.557
Total Other Income/Expenses Net
80.885
31.152
273.096
-1,213
-683.21
Income Before Tax
-8,925
-10,000
-9,948
-13,640
-6,781
Income from Continuing Operations
-8,925
-10,000
-9,948
-13,640
-6,781
Net Income
-8,925
-10,000
-9,948
-13,640
-6,781
Net Income available to common shareholders
-8,925
-10,000
-9,948
-13,640
-6,781
Basic EPS
-
-0.63
-0.93
-2.52
-1.71
Diluted EPS
-
-0.63
-0.93
-2.52
-1.71
Basic Average Shares
-
15,999
10,697
5,415
3,953
Diluted Average Shares
-
15,999
10,697
5,415
3,953
EBITDA
-
-9,881
-9,864
-6,068
-6,469